Hcr Wealth Advisors Eli Lilly & CO Transaction History

Hcr Wealth Advisors

$757 Million
Q3 2024

A detailed history of Hcr Wealth Advisors transactions in Eli Lilly & CO stock. As of the latest transaction made, Hcr Wealth Advisors holds 1,425 shares of LLY stock, worth $1.07 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

1,425

Previous 1,455 2.06%

Holding current value

$1.07 Million

Previous $1.32 Million 4.18%

% of portfolio

0.17%

Previous 0.19%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$772.14 - $960.02 $23,164 - $28,800	-30 Reduced 2.06%	1,425 $1.26 Million
Q2 2024 Aug 06, 2024	SELL	$724.87 - $909.04 $86,984 - $109,084	-120 Reduced 7.62%	1,455 $1.32 Million
Q1 2024 May 10, 2024	BUY	$592.2 - $792.28 $185,950 - $248,775	314 Added 24.9%	1,575 $1.23 Million
Q4 2023 Feb 09, 2024	BUY	$525.19 - $619.13 $60,396 - $71,199	115 Added 10.03%	1,261 $735,000
Q3 2023 Oct 20, 2023	SELL	$434.7 - $599.3 $49,121 - $67,720	-113 Reduced 8.98%	1,146 $615,000
Q2 2023 Aug 09, 2023	SELL	$350.74 - $468.98 $15,783 - $21,104	-45 Reduced 3.45%	1,259 $590,000
Q1 2023 May 12, 2023	BUY	$310.63 - $364.82 $32,305 - $37,941	104 Added 8.67%	1,304 $447,000
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $3,858 - $4,496	12 Added 1.01%	1,200 $439,000
Q3 2022 Nov 07, 2022	BUY	$296.48 - $337.87 $21,939 - $25,002	74 Added 6.64%	1,188 $384,000
Q3 2021 Nov 02, 2021	SELL	$221.6 - $272.71 $9,528 - $11,726	-43 Reduced 3.72%	1,114 $257,000
Q2 2021 Jul 21, 2021	BUY	$180.55 - $233.54 $5,958 - $7,706	33 Added 2.94%	1,157 $266,000
Q1 2021 May 13, 2021	SELL	$164.32 - $212.72 $44,530 - $57,647	-271 Reduced 19.43%	1,124 $210,000
Q4 2020 Feb 04, 2021	BUY	$130.46 - $172.63 $181,991 - $240,818	1,395 New	1,395 $236,000
Q3 2020 Nov 05, 2020	SELL	$146.22 - $169.13 $194,326 - $224,773	-1,329 Closed	0 $0
Q2 2020 Jul 30, 2020	BUY	$136.42 - $164.18 $181,302 - $218,195	1,329 New	1,329 $217,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hcr Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Hcr Wealth Advisors with notifications on news.

Account

Hcr Wealth Advisors Eli Lilly & CO Transaction History